Search research articles
Contact Us
Filters
Showing results (261-270 of 460) with videos related to
Page
of 46
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science
Mitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Cytotherapy
|
November 3, 2018
Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas
Nirav N Shah, Sarah J Nagle, Drew A Torigian, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2024
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α
Christopher Roselle, Izumi Horikawa, Linhui Chen, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2018
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Michael M Boyiadzis, Madhav V Dhodapkar, Renier J Brentjens, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 24, 2024
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer
Uri Amit, Ugur Uslu, Ioannis I Verginadis, et al.
Blood
|
September 23, 2017
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia
Karen Thudium Mueller, Shannon L Maude, David L Porter, et al.
Nature Reviews. Drug Discovery
|
September 30, 2025
In vivo chimeric antigen receptor (CAR)-T cell therapy
Adrian Bot, Andrew Scharenberg, Kevin Friedman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
Michael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 3, 2013
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation
Anita J Kumar, Elizabeth O Hexner, Noelle V Frey, et al.
Blood Advances
|
April 14, 2023
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
Keisuke Watanabe, Angela M Gomez, Shunichiro Kuramitsu, et al.
Page
of 46
Search research articles
Search
Showing results (261-270 of 460) with videos related to
Sort By:
Page
of 46
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science
Mitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Cytotherapy
|
November 3, 2018
Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas
Nirav N Shah, Sarah J Nagle, Drew A Torigian, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2024
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α
Christopher Roselle, Izumi Horikawa, Linhui Chen, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2018
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Michael M Boyiadzis, Madhav V Dhodapkar, Renier J Brentjens, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 24, 2024
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer
Uri Amit, Ugur Uslu, Ioannis I Verginadis, et al.
Blood
|
September 23, 2017
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia
Karen Thudium Mueller, Shannon L Maude, David L Porter, et al.
Nature Reviews. Drug Discovery
|
September 30, 2025
In vivo chimeric antigen receptor (CAR)-T cell therapy
Adrian Bot, Andrew Scharenberg, Kevin Friedman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
Michael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 3, 2013
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation
Anita J Kumar, Elizabeth O Hexner, Noelle V Frey, et al.
Blood Advances
|
April 14, 2023
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
Keisuke Watanabe, Angela M Gomez, Shunichiro Kuramitsu, et al.
Page
of 46